Skip to content

Clinical trials

Phase 3 Uterine Cervical Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 3 Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20071
20091
20111
20121
20151
20171
20182
20201
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
GlaxoSmithKline3
European Organisation for Research and Treatment of Cancer - EORTC2
Advenchen Laboratories, LLC1
Grupo Español de Investigación en Cáncer de Ovario1
Institut Claudius Regaud1
Seagen, a wholly owned subsidiary of Pfizer1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms15
Papillomavirus Infections4
Endometrial Neoplasms2
Vaginal Neoplasms2
Adenocarcinoma1
Carcinoma1
Carcinoma, Adenosquamous1
Condylomata Acuminata1
Fallopian Tube Neoplasms1
Infections1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.